Vigil Neuroscience Inc (VIGL)
3.41
+0.21
(+6.56%)
USD |
NASDAQ |
Mar 28, 16:00
3.38
-0.03
(-0.88%)
After-Hours: 20:00
Vigil Neuroscience Cash from Investing (TTM): -65.14M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -65.14M |
September 30, 2023 | -76.06M |
June 30, 2023 | -91.80M |
March 31, 2023 | -69.78M |
December 31, 2022 | -0.921M |
Date | Value |
---|---|
September 30, 2022 | -0.676M |
June 30, 2022 | -0.367M |
March 31, 2022 | -0.346M |
December 31, 2021 | -0.204M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-91.80M
Minimum
Jun 2023
-0.204M
Maximum
Dec 2021
-33.92M
Average
-0.921M
Median
Dec 2022
Cash from Investing (TTM) Benchmarks
MaxCyte Inc | 54.98M |
NovaBay Pharmaceuticals Inc | -0.017M |
Palatin Technologies Inc | 9.293M |
iBio Inc | 8.285M |
Theriva Biologics Inc | -0.202M |